These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11312488)

  • 1. Platelet glycoprotein IIb/IIIa antagonists: perioperative implications.
    Sreeram GM; Sharma AD; Slaughter TF
    J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):237-40. PubMed ID: 11312488
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.
    Koster A; Meyer O; Fischer T; Kukucka M; Krabatsch T; Bauer M; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1254-5. PubMed ID: 11726910
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific glycoprotein IIb/IIIa antagonists and inflammation.
    Ercan E
    Int J Cardiol; 2004 Mar; 94(1):121-2. PubMed ID: 14996486
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet glycoprotein IIb/IIIa inhibitors.
    Rosove MH
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):65-76. PubMed ID: 15171958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mortality with long-term platelet glycoprotein IIb/IIIa antagonists: an explanation?
    Vermylen J; Hoylaerts M; Arnout J
    Circulation; 2001 Nov; 104(20):E109. PubMed ID: 11705839
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
    Konstantopoulos K; Mousa SA
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Maree A; Fitzgerald D
    Haematologica; 2001 Nov; 86(11 Suppl 2):45-8. PubMed ID: 11926777
    [No Abstract]   [Full Text] [Related]  

  • 8. GP IIb/IIIa blockade during peripheral artery interventions.
    Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH
    Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet glycoprotein IIb/IIIa inhibitors: overview and implications for the anesthesiologist.
    Chun R; Orser BA; Madan M
    Anesth Analg; 2002 Oct; 95(4):879-88. PubMed ID: 12351262
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
    Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
    Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond aspirin: how glycoprotein inhibitors ease acute coronary syndromes.
    MacCallum EM; Hanlon SJ; Byrne KH
    Dimens Crit Care Nurs; 2000; 19(3):14-9. PubMed ID: 11998001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reflections on GPIIb/IIIA inhibitors ... and all around ...].
    Neri Serneri GG
    G Ital Cardiol; 1999 Apr; 29(4):467-71. PubMed ID: 10327329
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute central retinal artery occlusionwith the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban.
    Hölschermann H; Krombach C; Jung A; Jacobi F; Tillmanns H; Weinand F
    Thromb Haemost; 2005 Sep; 94(3):684-6. PubMed ID: 16268493
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advance on clinical applications of platelet glycoprotein IIb/IIIa receptor inhibitors].
    Zhou P; Yan HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):274-7. PubMed ID: 21609538
    [No Abstract]   [Full Text] [Related]  

  • 15. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
    Bolognese L
    Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
    Harrington RA
    Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotics and thrombolytics in stroke.
    Mousa SA; Iqbal O; Fareed J
    Curr Opin Investig Drugs; 2002 Jun; 3(6):878-85. PubMed ID: 12137407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable.
    Leebeek FW; Boersma E; Cannon CP; van de Werf FJ; Simoons ML
    Eur Heart J; 2002 Mar; 23(6):444-57. PubMed ID: 11863347
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
    Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.